Cardiac Resynchronization Therapy Devices (CRT)

Cardiac Resynchronization Therapy Devices (CRT) are cardiac electrophysiology (EP) systems that include a small electronic device that is surgically implanted into a pocket of skin to help both ventricles contract together. They are also called biventricular pacemakers. These systems can be used for pacing only, or can include a built-in defibrillator.

Implicity provides a remote cardiac monitoring and research platform used by Independent Diagnostic Testing Facilities and medical centers to deliver high-quality care for patients with connected cardiac devices. On this platform, Implicity aggregates, normalizes and standardizes data from any implantable cardiac device across all manufacturers.

News | EP Lab

Implicity Signs U.S. Distribution Agreement With MicroPort CRM to Expand Remote Monitoring of Various Implanted Cardiac Devices

June 2, 2021 — Implicity, a leader in remote patient monitoring software and cardiac data management solutions ...

June 02, 2021

A device programmer showing the suspension of ICD therapies (orange bar, red arrow) with iPhone 12 laying over patient’s chest (green arrow) and fluoroscopy of iPhone 12 showing the circular magnet array (yellow arrow). Image from a small study at Henry Ford Hospital. Read the full study

News | EP Lab

FDA Warns Magnets in Cell Phones and Smart Watches May Affect Pacemakers and Other EP Devices

May 14, 2021 — The U.S. Food and Drug Administration (FDA) is advising patients and caregivers to keep any consumer ...

May 14, 2021

The Bluegrass Vascular Surfacer System is designed to reliably, efficiently and repeatedly gain central venous access by inserting the Surfacer System through the right femoral vein and navigating it up through the patient’s venous system with an exit point in the right internal jugular vein, the optimal location for placing a central venous catheter.

News | EP Lab

Case Report on CRT Lead Placement in Obstructed Veins Using Surfacer System

May 6, 2021 - Bluegrass Vascular Technologies announced the publication of a report documenting the clinical utility of ...

May 06, 2021

Medtronic is recalling some of its implantable cardioverter defibrillators (ICD) and cardiac resynchronization therapy (CRT-D) devices because of an unexpected and rapid decrease in battery life. The company said this is due to a short circuit and will cause some devices to produce a “Recommended Replacement Time” (first warning that the battery is low) earlier than expected. Some devices may progress from “Recommended Replacement Time” to full battery depletion within as little as one day.

Feature | EP Lab

Medtronic Recalls its ICDs and CRT-Ds Due to Risk of Rapid Battery Depletion

April 12, 2021 — Medtronic is recalling some of its implantable cardioverter defibrillators (ICD) and cardiac ...

April 12, 2021

The new ACC Electrophysiology (EP) Device Implant Registry, part of the National Cardiovascular Data Registry (NCDR) will include data on implantable cardioverter defibrillator (ICD) and cardiac resynchronization therapy defibrillator (CRT-D) procedures previously captured in the NCDR ICD Registry, as well as provide the flexibility to capture novel pacemaker procedures. The registry is aligned with the ACC’s Electrophysiology Accreditation program, fully supporting the program’s data requirements.

News | EP Lab

ACC Launches NCDR Electrophysiology Device Implant Registry

April 2, 2021 — Today, the American College of Cardiology (ACC) launched the Electrophysiology (EP) Device Implant ...

April 02, 2021

Integrating data from an array of implantable EP devices from different vendors can be difficult or require disconnected silos of data for different vendors. One solution that was recently introduced to integrate data from various vendors is the Optimize EP software, which allows viewing data from all device vendors in one platform to streamline workflows.

Feature | EP Lab | By Maninder Bedi, M.D.

The Future of Remote Monitoring is Streamlining of Cardiac Device Data Management

A few weeks ago, a patient of mine experienced a cardiac event — his heart stopped. Completely. However, his implantable ...

March 17, 2021

News | Cardiac Resynchronization Therapy Devices (CRT)

CRT May Benefit More Heart Failure Patients in New Analysis of REVERSE Trial

March 3, 2021 — Medtronic announced new results from the landmark REVERSE trial, evaluating outcomes of cardiac ...

March 03, 2021

News | Implantable Cardioverter Defibrillator (ICD)

iPhone 12 May Cause Implantable Cardioverter Defibrillators to Malfunction

January 8, 2020 — A new study published this week in HeartRhythm, the journal of the Heart Rhythm Society (HRS), found ...

January 08, 2021

Videos | EP Device Monitoring Systems

VIDEO: Rising Interest in Remote Monitoring of EP Devices in the COVID-19 Era

Robert Kowal, M.D., chief medical officer of the Medtronic cardiac rhythm and heart failure division, said there has ...

December 22, 2020

Biotronik's closed loop stimulation (CLS) technology helps reduce unexplained fainting in patients with recurrent episodes due to skipped heartbeats. #ESC2020

News | EP Lab

Study Shows Severe Fainting Can Be Treated with Cardiac Pacing Supported by Closed Loop Stimulation

September 8, 2020 - A new study presented at the 2020 European Society of Cardiology (ESC) Congress shows that Biotronik ...

September 08, 2020

News | EP Lab

FDA Clears Abbott Gallant ICD and CRT With Bluetooth Connectivity and Continuous Remote Monitoring

July 13, 2020 - The U.S. Food and Drug Administration (FDA) has approved Abbott's next-generation Gallant implantable ...

July 13, 2020

Left bundle branch (LBBP) activation imaging shown using wall motion color codes on echo imaging from Canon. #HRS2020 #heartrhythm2020

News | Cardiac Resynchronization Therapy Devices (CRT)

Left Bundle Branch Pacing is Feasible as a Novel Strategy For Cardiac Resynchronization Therapy

May 13, 2020 — Cardiac resynchronization therapy (CRT) using biventricular pacing (BVP) or His bundle pacing (HBP) is ...

May 13, 2020

Valentina Kutyifa, M.D., Ph.D., University of Rochester Medical Center, Rochester, N.Y., is doing research in the BIO-LIBRA Study to determine it ICD or CRT-D devices work better in men or women with heart failure often present with non-ischemic cardiomyopathy.

Feature | Cardiac Resynchronization Therapy Devices (CRT) | Valentina Kutyifa M.D., Ph.D.

BIO-LIBRA Study Evaluates Role of Sex and Device Type in Non-ischemic Cardiomyopathy

Cardiovascular disease is the leading cause of death for women in North America, and women with heart failure often ...

March 09, 2020

Earlier this year, Medtronic began a worldwide pivotal study evaluating its investigational Extravascular Implantable Cardioverter Defibrillator (EV ICD) system to treat dangerously fast heart rhythms. The EV ICD system is designed to deliver lifesaving defibrillation and pacing therapy via a device the same size as traditional, transvenous ICDs, but with a lead (thin wire) placed outside the heart and veins. The future of CRM device technology.

Feature | EP Lab | Hrishikesh Kadam

The Future of Cardiac Rhythm Management Device Technology

Cardiac rhythm management (CRM) devices in use today are evolving to raise the bar beyond monitoring and managing ...

November 11, 2019

FDA Approves Barostim Neo System for Advanced Heart Failure Patients. Similar to a pacemaker, the Barostim Neo System uses a pulse generator implanted below the collar bone with a lead that attaches to the carotid artery in the neck. It delivers electrical impulses to baroreceptors in the neck, which sense how blood is flowing through the carotid arteries and relays information to the brain. The brain, in turn, sends signals to the heart and blood vessels that relax the blood vessels.

Technology | Heart Failure

FDA Approves Pacemaker-like Device to Treat Heart Failure

August 19, 2019 — The U.S. Food and Drug Administration (FDA) granted market clearance the Barostim Neo System for the ...

August 19, 2019